The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Proposal aims to regulate the performance of non-profit entities in a controlled experimental environment, using the Regulatory Sandbox model to comply with STJ decision

Amidst the expansion of the medical market, regulatory tensions, and the entry of emerging countries like Brazil, the conference establishes itself as a strategic space for scenario analysis, political articulation, and global business

Experts warn of the urgent need for investments in hemp fiber processing and beneficiation

New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

Psychologist Maria Klien explains how CBD can support emotional care without replacing therapy, highlighting balance, safe information, and patient empowerment

Neuropediatrician highlights the potential of full spectrum cannabidiol, but access still faces judicial and bureaucratic barriers

Discover the benefits of cannabis in palliative care and how it helps relieve pain, nausea, and anxiety in cancer patients this Breast Cancer Awareness Month

Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

Veterinarian relies on medicinal cannabis to relieve pain, restore appetite, and improve quality of life for pets with tumors

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Understand how science organizes cannabis, its subspecies, varieties, and the historical and therapeutic importance of the plant

Curitiba welcomes its first exclusive medicinal cannabis pharmacy, in a market that grew from R$ 38.5 million in 2022 to R$ 237.8 million in 2025, while Paraná accounts for only 2.4% of sales, indicating great potential in the state with 11 million inhabitants

Discover what it takes to successfully enter the promising cannabis market, even in the face of regulatory challenges

Brazilian entrepreneur inaugurates USA Hemp Pharmaceuticals headquarters in Goiânia, expanding the brand's operations in Brazil with a focus on medical education, white label, and technology transfer of industrial hemp

With over 100 speakers, the Brazilian Cannabis Congress begins with major debates and promises three historic days at the largest event in Latin America.

Diagnosed with breast cancer at 32, Daiany Dias faced the challenges of traditional treatment and found an unexpected relief in medicinal cannabis. Learn how the plant helped reduce the side effects of chemotherapy and brought comfort amidst the battle against the disease.

Given up by doctors; Isabel lives an intense journey of experience, teachings, and gratitude in a race against the remaining time

With an initial investment of approximately R$106 million, the company offers sustainable innovation, quality, and pharmaceutical standards of excellence